How do I set a price alert for TECH?

To set a TECH price alert on Stock Alarm Pro, navigate to the TECH quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for TECH?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for TECH. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for Bio-Techne?

Stock Alarm Pro supports over 125 trigger types for TECH: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about TECH price changes?

TECH alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for TECH alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for TECH and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

Bio-Techne (TECH) Price Alerts

Demo Sign up Log In

Bio-Techne Corporation(TECH)

NASDAQClosing price · checked 4:30 PM ESTAbout this dataData status

$72.84▲0.04 (0.05%)

After Hours:$72.84+0.00 (+0.00%)

WatchlistChart Studio

TECH(TECH)

TECH

S&P 500, Nasdaq, Russell 2000 below the 50-day average

Market overview →Overview →

Explore More

TECH Financial Metrics

Explore 130+ historical metrics & ratios

Healthcare Stocks

More Healthcare stocks

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

TECH Fundamentals

Annual and trailing 12-month values

All metrics →All fundamentals →

TECH News

All news →

About

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Charles Kummeth

Website

bio-techne.com ↗

Leadership (14)

Bernie AndrussSenior Vice President of Bio-Techne Diagnostics Division

Gary J. LathamVice President & Chief Technology Officer

Peter SchuesslerSenior Vice President of EMEA & Commercial Effectiveness

David ClairVice President of Investor Relations

Dylan MalayterSenior Vice President of Reagent Solutions Division

James T. HippelExecutive Vice President of Finance & Chief Financial Officer

Kim KeldermanChief Executive Officer, President & Director

Luca CicchettiManaging Director

Martin WirtzSenior Vice President of Strategy & Corporate Development

Shane BohnenSenior Vice President, General Counsel, Corporate Secretary & Chief Sustainability Officer

Steve CrousePresident of Diagnostics & Spatial Biology Segment

Steven SilvermanSenior Vice President of Customer Experience

William A. GeistPresident of Protein Sciences Segment

Cheryl BethuneSenior Vice President & Chief Human Resources Officer

About

Outlook

12 analystsHold$73.00+0.2%

TrendUptrend0.4% above 50-day

Key Metrics

TTMAll charts →

Select a linked metric to explore its chart.

Market Cap$11.44B Revenue TTM$1.23B

Rev Growth FY27E+4.7%

Rev Growth YoY+0.9%Price / Sales9.3x P/E (TTM)37.5x

Fwd P/E FY27E35.5x

Net Income TTM$171.97M Free Cash Flow$308.20M Gross Margin65.8%Operating Margin19.6%Net Margin14.0%Return on Equity8.2%

Return on Assets6.5%

Debt / Equity (MRQ)0.13 Current Ratio (MRQ)2.28 EPS TTM$1.10

All TECH metrics →Financial statements →

Trading snapshot

Price & range

Prev Close

72.80

Open

72.82

Day Range72.66 – 72.86

72.66

72.86

52W Range43.20 – 72.88

43.20

72.88

100% of range

50-Day MA

72.53(+0.4%)

200-Day MA

63.34(+15.0%)

Volume & size

Avg Volume

2.8M

Valuation & risk

P/E (TTM)

37.5x

EPS (TTM)

—

Div Yield (TTM)

0.31%

Beta

1.19

Market-like

Momentum

RSI (14)

63

Bullish momentum

Upcoming Events

DEx-Dividend

Today

Nov 13

PDividend Pay

In 10 days

Nov 23

EEarnings Report

In 81 days

Feb 2

Explore More

S&P 500 Sector Leaderboards

Fundamental Metric Rankings

TECH Fundamentals

TECH News

About

Leadership (14)

About

Upcoming Events

Outlook

About

Leadership (14)

TECH Fundamentals

Key Metrics